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• Delayed eosinophil apoptosis contributes to tissue eosinophilia 
and is driven by IL-5
• Eosinophil activation leads to eosinophil cytolysis, a non-
apoptotic type of cell death
• Successful therapies delete eosinophils from tissues
• Specific cell death pathways should be considered as targets 
for anti-allergic therapies
The regulation of cell death in 
allergic rhinitis (AR) has been rel-
atively little investigated and its 
possible contribution to patho-
genesis largely ignored. As with 
other types of inflammatory re-
sponses, the local accumulation of 
different subgroups of leukocytes 
occurs during the initiation and 
maintenance phases, whereas in-
flammatory cell numbers decline 
in the resolution phase of allergic 
inflammation. The changes in cell 
numbers during inflammation are 
largely due to changes in rates, 
both of cell recruitment and of 
cell death. Important leukocyte 
subgroups believed to play criti-
cal roles in the pathophysiology of 
AR are the dendritic cells, T cells, 
mast cells, and eosinophils.
The contribution of cell death to 
the pathogenesis of allergic dis-
eases has recently been summa-
rized elsewhere. Although most 
of the reports published so far 
have not been studies with AR 
patients or animal models, one 
could expect that these findings 
should have relevance for AR. 
For instance, it is likely that epi-
thelial cell damage accompanies 
the allergic inflammation of the 
nasal mucosa. Moreover, the sus-
ceptibility of T cells for undergo-
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ing apoptosis might be regulated 
similarly to other inflammatory 
responses.
The mode of cell death in eosino-
phils has been the subject of most 
studies on cell death regulation 
and inflammation in AR. Eosino-
phils accumulate in the nasal mu-
cosa not only owing to increased 
recruitment, but also as a conse-
quence of delayed apoptosis. The 
major eosinophil survival factor 
seems to be IL-5. Interestingly, 
allergen-specific immunotherapy 
reduced IL-5 production by CD4+ 
T cells in AR patients and anti-IL-5 
antibody therapy has been effec-
tive in patients with nasal polypo-
sis. The beneficial effect of topical 
corticosteroid therapy in AR is 
probably also largely a conse-
quence of the reduced expression 
of Th2 cytokines, including IL-5. 
Besides delayed eosinophil ap-
optosis, eosinophil degranulation 
and cytolysis, which represents a 
form of non-apoptotic cell death, 
have also been observed in AR. It 
has been suggested that eosino-
phil cytolysis occurs without prior 
extensive degranulation and is the 
result of major activation mecha-
nisms distinct from degranulation. 
The molecular mechanisms of eo-
sinophil activation resulting in cy-
tolysis remain to be investigated.
A look at the molecular basis of 
many allergic diseases reveals a 
cell death component that either 
accounts for the disease or con-
tributes to disease progression. 
For instance, following eosinophil 
activation in AR, signaling path-
ways mediating both cell survival 
and cell death are activated. Re-
gardless the cellular response, the 
inflammation is maintained (Fig. 
1). Therefore, current and future 
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Figure 1 Eosinophil activation and their cellular life span. The activation of eosinophils can change their cellular life 
span. Either eosinophils exhibit a prolonged life span owing to cytokine-mediated delayed apoptosis or they undergo 
cytolysis. With delayed apoptosis, eosinophils contribute to the maintenance of inflammation by multiple mechanisms. 
Cytolysis, on the other hand, is associated with massive granule protein secretion. Moreover, cytolysis most likely results 
in the release of damage-associated molecular pattern molecules (DAMPs), which are known to trigger inflammatory 
responses. The release of DAMPs from cytolytic eosinophils remains to be further studied; hence, this pathway is 
indicated with dashed arrows.
anti-allergic therapies should also 
be analyzed with respect to their 
impact on cell death pathways.
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